Literature DB >> 9211215

A topography of psychiatric disorders among correction officers.

A J Tartaglini1, D A Safran.   

Abstract

This study assessed the nature, scope, and work-related impact of psychiatric disorders among correction officers. It also examined the effect of psychiatric diagnoses on occupational functioning. Medical charts of 1029 correction officers with complaints of psychological distress were reviewed for DSM-III-R diagnoses and duration of disability. Subjects evinced a wide range of psychiatric conditions, accounting for a substantial loss of full-duty workdays. The most frequently observed diagnoses were V Codes, mood and adjustment disorders. The most disabling conditions in terms of duration of disability were mood, anxiety, and personality disorders. V Codes accounted for the highest cumulative duration of disability among all officers. Results suggest that psychiatric disability among correction officers is most often a function of V-Code conditions, as opposed to major Axis I or II psychopathology.

Entities:  

Mesh:

Year:  1997        PMID: 9211215     DOI: 10.1097/00043764-199706000-00012

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  2 in total

1.  Personality dysfunction and employment dysfunction: double, double, toil and trouble.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2010-03

2.  CCWORK protocol: a longitudinal study of Canadian Correctional Workers' Well-being, Organizations, Roles and Knowledge.

Authors:  Rosemary Ricciardelli; Elizabeth Andres; Meghan M Mitchell; Bastien Quirion; Diane Groll; Michael Adorjan; Marcella Siqueira Cassiano; James Shewmake; Martine Herzog-Evans; Dominique Moran; Dale C Spencer; Christine Genest; Stephen Czarnuch; James Gacek; Cramm Heidi; Katharina Maier; Jo Phoenix; Michael Weinrath; Joy MacDermid; Margaret McKinnon; Stacy Haynes; Helen Arnold; Jennifer Turner; Anna Eriksson; Alexandra Heber; Gregory Anderson; Renee MacPhee; Nicholas Carleton
Journal:  BMJ Open       Date:  2021-12-08       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.